MX340736B - Vacunas y componentes de vacunas para inhibicion de celulas microbianas. - Google Patents

Vacunas y componentes de vacunas para inhibicion de celulas microbianas.

Info

Publication number
MX340736B
MX340736B MX2010003319A MX2010003319A MX340736B MX 340736 B MX340736 B MX 340736B MX 2010003319 A MX2010003319 A MX 2010003319A MX 2010003319 A MX2010003319 A MX 2010003319A MX 340736 B MX340736 B MX 340736B
Authority
MX
Mexico
Prior art keywords
phage
polynucleotides
polypeptides
mru
cells
Prior art date
Application number
MX2010003319A
Other languages
English (en)
Other versions
MX2010003319A (es
Inventor
Heinz Altermann Eric
Trevor Attwood Graeme
Dong Li
John Kelly William
Kong Zhanhao
Leahy Sinead
Original Assignee
Pastoral Greenhouse Gas Res Ltd *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pastoral Greenhouse Gas Res Ltd * filed Critical Pastoral Greenhouse Gas Res Ltd *
Publication of MX2010003319A publication Critical patent/MX2010003319A/es
Publication of MX340736B publication Critical patent/MX340736B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/20—Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
    • Y02P60/22—Methane [CH4], e.g. from rice paddies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)

Abstract

La presente invención se refiere a componentes de células microbianas que con útiles para la producción de anticuerpos, incluyendo péptidos, polipéptidos que comprenden estos péptidos, polinucleótidos que codifican estos péptidos o polipéptidos y anticuerpos dirigidos a estos péptidos polipéptidos y polinucleótidos. La presente invención también comprende vectores de expresión y células huésped para producir estos péptidos, polipéptidos, polinucleótidos y anticuerpos. La presente invención comprende además métodos y composiciones, especialmente composiciones de vacuna para detectar, dirigir e inhibir células microbianas, especialmente células de metanógeno, utilizando uno o más de los péptidos, polipéptidos, polinucleótidos, anticuerpos, vectores de expresión en células huésped descritos.
MX2010003319A 2007-09-25 2008-09-25 Vacunas y componentes de vacunas para inhibicion de celulas microbianas. MX340736B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US97510407P 2007-09-25 2007-09-25
US98984007P 2007-11-22 2007-11-22
US98984107P 2007-11-22 2007-11-22
PCT/NZ2008/000249 WO2009041832A2 (en) 2007-09-25 2008-09-25 Vaccines and vaccine components for inhibition of microbial cells

Publications (2)

Publication Number Publication Date
MX2010003319A MX2010003319A (es) 2010-09-10
MX340736B true MX340736B (es) 2016-07-22

Family

ID=40511642

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2010003328A MX2010003328A (es) 2007-09-25 2008-09-25 Peptidos y polipeptidos permeabilizantes celulares para celulas microbianas.
MX2010003319A MX340736B (es) 2007-09-25 2008-09-25 Vacunas y componentes de vacunas para inhibicion de celulas microbianas.
MX2010003321A MX2010003321A (es) 2007-09-25 2008-09-25 Polipeptidos y polinucleotidos del fago qmru y sus usos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2010003328A MX2010003328A (es) 2007-09-25 2008-09-25 Peptidos y polipeptidos permeabilizantes celulares para celulas microbianas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2010003321A MX2010003321A (es) 2007-09-25 2008-09-25 Polipeptidos y polinucleotidos del fago qmru y sus usos.

Country Status (17)

Country Link
US (7) US8592556B2 (es)
EP (5) EP3327030B1 (es)
JP (5) JP5558356B2 (es)
CN (4) CN102015755A (es)
AR (3) AR068553A1 (es)
AU (4) AU2008304018A1 (es)
BR (5) BRPI0817299A8 (es)
CA (3) CA2700129C (es)
CL (3) CL2008002859A1 (es)
DK (3) DK2203466T3 (es)
ES (3) ES2587595T3 (es)
MX (3) MX2010003328A (es)
NZ (1) NZ745324A (es)
RU (1) RU2528854C2 (es)
UY (3) UY31361A1 (es)
WO (3) WO2009041830A2 (es)
ZA (1) ZA201001933B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0817299A8 (pt) * 2007-09-25 2019-01-29 Pastoral Greenhouse Gas Res Limited vacinas e componentes de vacina para inibição de células microbianas
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
KR101701890B1 (ko) * 2009-06-26 2017-02-02 뤼산도 아게 항균제
EP3058950B1 (en) * 2009-06-26 2020-03-04 Lysando AG Antimicrobial agents
AR077992A1 (es) 2009-08-27 2011-10-05 Pastoral Greenhouse Gas Res Ltd Secuencia del genoma completo del metanogeno methanobrevibacter ruminantium
SG184836A1 (en) * 2010-04-27 2012-11-29 Lysando Ag Method of reducing biofilms
EP2899200B1 (en) * 2012-09-19 2020-05-06 Gemvax & Kael Co., Ltd. Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
CN105658796B (zh) * 2012-12-12 2021-10-26 布罗德研究所有限公司 用于序列操纵的crispr-cas组分系统、方法以及组合物
US10760064B2 (en) 2013-03-15 2020-09-01 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
US9885033B2 (en) 2013-03-15 2018-02-06 The General Hospital Corporation Increasing specificity for RNA-guided genome editing
US10011850B2 (en) 2013-06-21 2018-07-03 The General Hospital Corporation Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing
CA2930015A1 (en) 2013-11-07 2015-05-14 Editas Medicine, Inc. Crispr-related methods and compositions with governing grnas
WO2016073433A1 (en) * 2014-11-06 2016-05-12 E. I. Du Pont De Nemours And Company Peptide-mediated delivery of rna-guided endonuclease into cells
CN104789675A (zh) * 2015-04-15 2015-07-22 江苏师范大学 一种检测荷斯坦奶牛瘤胃微生物的方法
WO2016178207A1 (en) * 2015-05-04 2016-11-10 Ramot At Tel-Aviv University Ltd. Methods and kits for fragmenting dna
US9512446B1 (en) 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US9926546B2 (en) 2015-08-28 2018-03-27 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
DK3484996T3 (da) * 2016-07-14 2020-12-07 Basf Se Fermenteringsmedium, der omfatter et chelateringsmiddel
KR102747205B1 (ko) * 2016-12-29 2024-12-31 일루미나, 인코포레이티드 세포 구획 내의 생체분자에 대한 직교 접근 및 그의 태그부착을 위한 분석 시스템
WO2018126499A1 (zh) 2017-01-05 2018-07-12 深圳迈瑞生物医疗电子股份有限公司 网织红细胞模拟粒子、血小板模拟粒子制备方法及质控物
US10745439B2 (en) * 2017-03-20 2020-08-18 Regents Of The University Of Minnesota Kinase substrates and methods of use thereof
WO2019147743A1 (en) 2018-01-26 2019-08-01 Massachusetts Institute Of Technology Structure-guided chemical modification of guide rna and its applications
CN116349651A (zh) * 2018-03-19 2023-06-30 瑞泽恩制药公司 使用crispr/cas系统对动物进行转录调制
CN113646330A (zh) 2018-11-14 2021-11-12 鲁比克治疗股份有限公司 工程化cd25多肽及其用途
JP7619941B2 (ja) 2018-11-14 2025-01-22 アイバイオ， インク． Ｃｄ２５抗体
CN109627301B (zh) * 2019-02-18 2022-08-05 浙江新银象生物工程有限公司 Nisin固体稳定剂开发及应用
WO2021185948A1 (en) * 2020-03-19 2021-09-23 Micreos Human Health B.V. A stabilized protein of interest
US20230072496A1 (en) * 2020-04-10 2023-03-09 Liberty Biosecurity, Llc Polypeptide compositions and uses thereof
CN112143747B (zh) * 2020-09-09 2022-09-13 昆明理工大学 一种噬菌体裂解酶及其基因、基因重组表达载体与应用
PT4037666T (pt) 2020-12-08 2024-06-25 Ruminant Biotech Corp Ltd Aperfeiçoamentos de dispositivos e métodos para administração de substâncias a animais
CN112961217B (zh) * 2021-03-19 2022-11-08 江苏元本生物科技有限公司 一种靶向Siglec-15的噬菌体多肽
CN113121705B (zh) * 2021-04-19 2023-03-24 成都英普博集生物科技有限公司 用于制备短肽混合物的融合蛋白、目的多肽、短肽混合物的制备方法及应用
EP4554616A1 (en) * 2022-07-11 2025-05-21 Arkea Bio Corp. Compositions and methods for reducing methane emissions in ruminant populations
CN115417927A (zh) * 2022-09-08 2022-12-02 南京松天盛科生物科技有限公司 小鼠腹水致敏物及其应用
AR130970A1 (es) * 2022-11-03 2025-02-05 Helix Nanotechnologies Inc Vacunas ruminales y metanógenas y usos de estas
CN115938486B (zh) * 2022-12-06 2023-11-10 内蒙古农业大学 基于图神经网络的抗菌性乳酸菌株筛选方法
WO2025219570A1 (en) 2024-04-17 2025-10-23 Johannes Kepler Universität Linz Composition for inhibiting protein translocation and methods using the same
WO2025233675A1 (en) * 2024-05-10 2025-11-13 Institut Pasteur Use of talosaminidase to regulate populations of archaeal methanogens in industrial, agricultural and medical settings

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US159861A (en) * 1875-02-16 Improvement in brooms
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
JPH01500746A (ja) * 1983-05-03 1989-03-16 エス．エス．エム．インターナショナル　ケミカル　カンパニー　リミテッド 改善された医薬活性を有する組成物および獣医用の目的にそれを使用すること
GB8815968D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Veterinary devices
JPH05219927A (ja) * 1992-02-14 1993-08-31 Gumma Pref Gov 飼料の混合装置及び混合飼料の製造方法
JP3651915B2 (ja) * 1993-06-30 2005-05-25 財団法人神奈川科学技術アカデミー シグナル配列ペプチドをコードするｄｎａ断片の探索法及びそのためのベクター
DK0724454T3 (da) * 1993-10-19 2004-07-12 Commw Scient Ind Res Org Fremgangsmåde til forbedring af drövtyggerdyrs eller drövtyggerlignende dyrs udnyttelse af næringsstoffer
JPH09507121A (ja) 1993-10-26 1997-07-22 アフィマックス テクノロジーズ ナームロゼ ベノートスハップ 生物学的チップ上の核酸プローブアレー
NZ278977A (en) 1994-01-20 1997-03-24 Pastoral Agric Res Inst Nz Ltd Sustained release bolus for ruminants
ES2207644T3 (es) 1994-01-20 2004-06-01 Agresearch Limited Dispositivo de administracion a los rumiantes de sustancias utiles.
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
AUPN353695A0 (en) 1995-06-14 1995-07-06 Commonwealth Scientific And Industrial Research Organisation Immunogenic preparation and method for improving the productivity of ruminant animals
WO1998007830A2 (en) * 1996-08-22 1998-02-26 The Institute For Genomic Research COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
US5985907A (en) * 1998-08-12 1999-11-16 Health Research, Inc. Method for inhibiting growth of methanogens
WO2002077183A2 (en) 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
AU2002326949A1 (en) 2001-09-18 2003-05-12 The Board Of Regents Of The University Of Nebraska Method for the inhibition of methanogenesis
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
US20060068386A1 (en) * 2002-03-04 2006-03-30 Alexei Slesarev Complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof
SE523209C2 (sv) * 2002-05-14 2004-04-06 Akzo Nobel Nv Förfarande för att reducera metanbildningen från matspjälkningsaktiviteter hos djur
US20100048595A1 (en) 2005-03-23 2010-02-25 Washington University In St. Louis Use of archaea to modulate the nutrient harvesting functions of the gastrointestinal microbiota
BRPI0817299A8 (pt) * 2007-09-25 2019-01-29 Pastoral Greenhouse Gas Res Limited vacinas e componentes de vacina para inibição de células microbianas
CN101434924A (zh) * 2008-12-17 2009-05-20 中南大学 一种分离严格厌氧产甲烷古菌的方法
AR077992A1 (es) * 2009-08-27 2011-10-05 Pastoral Greenhouse Gas Res Ltd Secuencia del genoma completo del metanogeno methanobrevibacter ruminantium
CN101864362B (zh) * 2010-05-19 2012-05-09 江苏加德绿色能源有限公司 一种复合微生物菌剂及其应用
DE102011119230B4 (de) * 2011-11-23 2013-07-11 Audi Ag Kraftwagen-Blinkleuchte und Verfahren zum Betreiben einer Blinkleuchte
JP2016511630A (ja) * 2012-12-21 2016-04-21 ダニスコ・ユーエス・インク 代案の下流メバロン酸経路を使用するイソプレン、イソプレノイド、およびイソプレノイド前駆体の生成

Also Published As

Publication number Publication date
JP2015042166A (ja) 2015-03-05
CA2700164A1 (en) 2009-04-02
UY31361A1 (es) 2009-04-30
CA2700162C (en) 2018-08-14
AR068553A1 (es) 2009-11-18
UY31359A1 (es) 2009-04-30
BRPI0817299A2 (pt) 2015-06-16
EP3327030B1 (en) 2021-07-21
WO2009041830A3 (en) 2009-07-02
US8592556B2 (en) 2013-11-26
US20210332087A1 (en) 2021-10-28
BRPI0817312B1 (pt) 2018-05-29
US10995120B2 (en) 2021-05-04
AR068551A1 (es) 2009-11-18
AU2014210649A1 (en) 2014-09-04
AU2008305846A1 (en) 2009-04-02
CN101932595B (zh) 2016-02-10
JP5558356B2 (ja) 2014-07-23
RU2010116163A (ru) 2011-11-10
US9296789B2 (en) 2016-03-29
US20100209998A1 (en) 2010-08-19
WO2009041832A2 (en) 2009-04-02
US11926647B2 (en) 2024-03-12
EP2203466A2 (en) 2010-07-07
BRPI0817312A2 (pt) 2015-03-17
DK2203467T3 (en) 2017-03-27
RU2528854C2 (ru) 2014-09-20
CN101918431B (zh) 2014-10-08
CN107129524B (zh) 2023-11-21
DK3327030T3 (da) 2021-10-04
WO2009041831A9 (en) 2009-11-05
JP2010539927A (ja) 2010-12-24
UY31360A1 (es) 2009-04-30
US10590170B2 (en) 2020-03-17
JP2017046704A (ja) 2017-03-09
CN107129524A (zh) 2017-09-05
ES2625144T3 (es) 2017-07-18
AU2008304018A1 (en) 2009-04-02
EP3327030A1 (en) 2018-05-30
MX2010003328A (es) 2010-08-16
CN101932595A (zh) 2010-12-29
EP3936516A1 (en) 2022-01-12
EP2203467A4 (en) 2011-04-13
CN101918431A (zh) 2010-12-15
JP6067209B2 (ja) 2017-01-25
NZ745324A (en) 2023-02-24
NZ780936A (en) 2024-08-30
ES2895908T3 (es) 2022-02-23
CA2700164C (en) 2018-05-29
US20200325180A1 (en) 2020-10-15
MX2010003321A (es) 2010-08-03
JP5552053B2 (ja) 2014-07-16
EP2203466A4 (en) 2011-04-13
BRPI0817299A8 (pt) 2019-01-29
WO2009041830A2 (en) 2009-04-02
US20140220636A1 (en) 2014-08-07
US20100221185A1 (en) 2010-09-02
JP2010539928A (ja) 2010-12-24
EP2203470A2 (en) 2010-07-07
CL2008002859A1 (es) 2009-03-06
CN102015755A (zh) 2011-04-13
AU2008304019A1 (en) 2009-04-02
EP2203466B1 (en) 2016-04-06
US20100209999A1 (en) 2010-08-19
CL2008002860A1 (es) 2009-06-05
EP2203470A4 (en) 2011-04-13
AU2014210649B2 (en) 2016-09-08
BR122020023381B1 (pt) 2021-09-08
EP2203467B1 (en) 2016-12-14
US8586709B2 (en) 2013-11-19
CA2700129A1 (en) 2009-04-02
ES2587595T3 (es) 2016-10-25
BR122021010737B1 (pt) 2021-09-21
MX2010003319A (es) 2010-09-10
CL2008002861A1 (es) 2009-03-06
JP2010539926A (ja) 2010-12-24
CA2700162A1 (en) 2009-04-02
US20170342112A1 (en) 2017-11-30
BR122021010729B1 (pt) 2022-02-15
WO2009041832A9 (en) 2009-10-22
AR068552A1 (es) 2009-11-18
DK2203466T3 (en) 2016-07-25
WO2009041832A3 (en) 2009-06-11
EP2203467A1 (en) 2010-07-07
WO2009041831A1 (en) 2009-04-02
CA2700129C (en) 2021-07-20
WO2009041830A9 (en) 2009-08-27
ZA201001933B (en) 2013-10-30

Similar Documents

Publication Publication Date Title
MX2010003321A (es) Polipeptidos y polinucleotidos del fago qmru y sus usos.
PH12013501101A1 (en) Immunosuppressive polypeptides and nucleic acids
AU2016204376A1 (en) MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer
MY152503A (en) 4-phenyl-pyrane-3, 5-diones, 4-phenyl-thiopyrane-3, 5-diones and cyclohexanetriones as novel herbicides
TN2010000269A1 (en) 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2- phenylcyclohexane -1,3,5 - triones as herbicides
AU2010226726A8 (en) Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
WO2009108860A8 (en) Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders
MX2009008222A (es) Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama.
WO2010099161A8 (en) Micrornas in never-smokers and related materials and methods
WO2007089798A3 (en) Methods of preparing and characterizing mesenchymal stem cell aggregates and uses thereof
MY166652A (en) Modified fillers and elastomeric composites comprising same
WO2007101698A3 (en) Modified molecules which promote hematopoiesis
SI2865755T1 (sl) Intaktne minicelice, ki so izvedene iz bakterij in vključujejo regulatorno RNA
ZA200807714B (en) Gene disruptions, compositions and methods relating thereto
MX2009009883A (es) Resinas politioeter amina y las composiciones que las comprenden.
WO2011062962A3 (en) Smndelta7 degron: novel compositions and methods of use
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
DE602008004167D1 (en) 6-phenyl-1h-imidazoä4,5-cü-pyridin-4-carbonitrilderivate als cathepsin-hemmer
ZA200808498B (en) Novel gene disruptions,compositions and methods relating thereto
IL218025A0 (en) Vector comprising mannose promoter and mannose promoter, compositions comprising the same and uses thereof
MX2010002950A (es) Metodos y composiciones para deteccion de ehrlichia chaffeensis (vlpt).
IL213026A0 (en) TNA-a INHIBITING PEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF
WO2010096754A8 (en) Compositions and methods to prevent and/or treat cancer with pa -card
MX2010002947A (es) Metodos y composiciones para deteccion de ehrlichia chaffeensis (p120).
MY150196A (en) Rumc peptides with antimicrobial activity

Legal Events

Date Code Title Description
FG Grant or registration
HH Correction or change in general